BillionToOne BLLN 深 滬
等待開盤 10-08 09:30:00 美东时间
95.75
-4.190
-4.19%
華盛通- 最 高99.60
- 今 開99.42
- 成交量 67.77万股
- 最 低 94.52
- 昨 收 99.94
- 總市值 45.18亿
- 52周最高 150.44
- 市盈率 靜 1503.14
- 換手率 1.44%
- 52周最低 61.96
- 委 比 97.37%
- 總股本 4718.70万
- 歷史最高 150.44
- 量 比 0.97
- 振 幅 5.08%
- 歷史最低 61.96
- 每 手 1
- 風險率 17.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅1654.39%！Ascendiant Capital上调NRX Pharmaceuticals(NRXP)目标价至50美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从49美元升至50美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从24美元升至25美元
10-02 08:33
Guggenheim Maintains Buy on BillionToOne, Raises Price Target to $128
Guggenheim analyst Subbu Nambi maintains BillionToOne (NASDAQ:BLLN) with a Buy and raises the price target from $125 to $128.
10-01 22:09
美股牛股 | Grail升逾15%，Galleri癌症筛查工具获FDA专家组支持；Everpure升逾11%，2028财年业绩预测超分析师预期
Grail升逾15%，Galleri癌症筛查工具获FDA专家组支持；Everpure升逾11%，2028财年业绩预测超分析师预期>>
09-25 19:00
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
The Centers for Medicare & Medicaid Services plans to align its 2027 clinical laboratory fee schedule rates with private sector payer rates, aiming to curb excessive Medicare payments and save taxpayers an estimated $1 billion annually. • BillionToOne stock is facing resistance. What’s pulling BLLN ...
09-24 02:09
美股牛股 | VKTX升近36%，给药频率减半仍维持97%减重；Vicor升逾19%，上调Q3营收指引
减肥药传来捷报！VKTX升近36%，给药频率减半仍维持97%减重；Vicor升逾19%，上调Q3营收指引；Grab Holdings升近9%，CEO增持近3000万美元股份>>
09-23 19:22
美股大行评级 | 最高735美元！戴尔科技绩后获11家大行上调目标价；MongoDB绩后分歧大，9家上调；4家下调；派拓网络、GitLab、美敦力获多家大行上调目标价
今日重点评级关注：Tigress Financial：维持Liftoff Mobile"买入"评级，目标价从39美元升至41美元；奥本海默：维持SpaceX"跑赢大市"评级，目标价从250美元升至280美元
09-03 13:50
Canaccord Genuity Initiates Coverage On BillionToOne with Buy Rating, Announces Price Target of $120
Canaccord Genuity analyst Kyle Mikson initiates coverage on BillionToOne (NASDAQ:BLLN) with a Buy rating and announces Price Target of $120.
09-02 23:42
BillionToOne Publishes NIPT Study Titled A Prospective, Multi-Site Study Of Performance Of Cell-Free DNA Testing For Recessive Conditions In A Large, General-Risk Pregnancy Population
BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced publication of A Prospective, Multi-Site Study of Performance of Cell-Free DNA Testing for Recessive Conditions in a Lar...
08-19 00:16
BillionToOne, Inc. Class A Signals Robust Growth
BillionToOne, Inc. Class A (($BLLN)) has held its Q2 earnings call. Read on for...
08-12 08:24
美股周涨跌榜 | 心血管药企Braveheart Bio上市首周大升66.7%；多只绩优股飙升！IOVA周升逾55.8%，Atlassian周升逾47%
心血管药企Braveheart Bio上市首周大升66.7%；多只绩优股飙升！IOVA周升逾55.8%，季报营收创新高；Atlassian周升逾47%，第四财季营收同比增长27.6%>>
08-08 09:48
